Carl Icahn's position in Illumina is currently worth $87.2 Million. That's 0.63% of their equity portfolio (11th largest holding). The investor's estimated purchase price is $90.5 Million, resulting in a loss of 3.6%.
2/2 © Reuters. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake 2/2 By...
https://www.investing.com/news/stock-market-news/insider-trades--hedge-fund-moves-carl-icahn-tosses-out-illumina-chair-3093037
Shareholders of the world’s largest gene sequencing company Illumina, (NASDAQ:ILMN), have proven their disapproval of the board’s past decisions by…
Activist investor Carl Icahn is seeking to unseat Illumina’s chairman and its CEO, and put three of his own people on the company’s board.